The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis

The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis
GSE207910 · GEO

TL;DR — A 0 bytes bulk RNA-seq deposit (GSE207910, 0 file(s), human) in the MASLD / NAFLD / NASH data lake. Open, verified-on-disk.


0. Summary

Biological premise.

This deposit is included in the MASLD (metabolic dysfunction-associated steatotic liver disease) data lake for the following curated reason: relevance recorded in the MASLD portal-expansion shortlist. No free-text abstract was exposed by the repository API; the measured file inventory below is authoritative for what the deposit contains.

Every file in this dataset is a bulk RNA-seq readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from GEO.

Assay and processing.

Modality: bulk RNA-seq (repository subtype: bulk RNA-seq). Tier-1 (must-have) for this modality = raw/normalized gene × sample expression matrix + per-sample design; Tier-2 (recommended) = author DE tables, design/contrasts, gene annotation; Tier-3 (optional / raw) = raw reads (FASTQ/BAM in SRA/ENA), reference build + quantifier version. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.

Sources.

DiseaseMASLD / NAFLD / NASH
Assay / modalitybulk RNA-seq — bulk RNA-seq
Organismshuman
RepositoryGEO — NCBI GEO FTP
AccessionGSE207910
AccessPublic (open); files mirrored in this dataset's input/ folder.
Number of studies1
Number of files0
Total size0 bytes (≈ 0 bytes)
Biological samples14 — "sample" = one deposit-declared sample/assay record

1. Datasets — sample sources, protocols, experiment design and metadata

Landed sources at a glance.

SourceAccessFiles
GEOpublic / OPEN0

The deposit at a glance.

AccessionDescriptionOrganismSamplesScale
GSE207910The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell acthuman140 files · 0 bytes

GSE207910 — The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis

GEO record · 0 files · 0 bytes

  • Sample source. human material; MASLD/NAFLD/NASH context.

  • Samples and retention. 14 deposit-declared samples ("sample" = one repository sample/assay record).

  • Experiment design. Repository subtype: bulk RNA-seq; disease context MASLD/NAFLD/NASH.

  • Metadata available. See the annotated file table below; per-sample metadata ships in the ISA-Tab / SDRF / metadata file(s) where present.

  • Files (annotated).

    FileWhat it is
  • How this experiment became a dataset. GSE207910 resolved via the GEO record API → 0 open file(s) fetched into this dataset's input/ folder → sizes verified on disk (0 bytes (≈ 0 bytes)).

  • Completeness (bulk RNA-seq). No canonical Tier-1 slot auto-detected among the landed files. Not detected among landed files: expression matrix (Tier-1); per-sample design (Tier-1). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)


2. Analyses this atlas supports

  • Differential expression. Start from this dataset's input/ folder (expression matrix) to run DESeq2/edgeR or limma contrasts and MASLD signatures.
  • Cross-cohort MASLD integration. Combine this deposit (GSE207910) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.

Reproduce. All files are in this dataset's input/ folder; the source of record is GSE207910 (https://ftp.ncbi.nlm.nih.gov/geo/series/GSE207nnn/GSE207910/suppl/). Re-fetch with the MASLD crawler (masld_download_pass.py --only GSE207910); sizes are verified on disk and recorded in this dataset's metadata.json.


Citation

The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. GEO accession GSE207910. https://ftp.ncbi.nlm.nih.gov/geo/series/GSE207nnn/GSE207910/suppl/ PMID 35923112

About this dataset

This 10x Genomics dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 14 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.